key: cord-0805601-63cr2m2t authors: Toky Rakotomalala, Randriamahazo; Andrianarivelo, Andry Maharo; Rakotoarivo, Andry Toky; Raheritiana, Todisoa Mahenina; Rakotovao, Luc Andriamiadana; Randriamanantany, Zely Arivelo; Rakoto Alson, Aimée Olivat; Rasamindrakotroka, Andry title: Evaluation of antigen-based rapid detection test for the diagnosis of SARS CoV-2 in low-income countries date: 2021-12-09 journal: J Virol Methods DOI: 10.1016/j.jviromet.2021.114409 sha: 5efa4363755c5813860775dc6d062f5932214837 doc_id: 805601 cord_uid: 63cr2m2t BACKGROUND: In the context of the Covid-19 pandemic and following the increasing number of suspicious Covid-19 cases in Madagascar, Malagasy laboratories are overflowed mainly due to lack of human resource and available material restriction. The development and validation of rapid and easy-to-perform diagnostic methods are worth of interest and high priority. The aim of this prospective study was to evaluate the performances of a rapid immunochromatographic test for the detection of SARS-CoV-2 antigen, in comparison to Reverse transcription polymerase chain reaction (RT-PCR). METHODS: The fluorescence immunochromatographic SARS-CoV-2 antigen test StandardTM Q COVID-19 Ag Test (SD Biosensor Republic Korea) was evaluated in samples derived from patients who were examined for disease categories. Diagnostic accuracy was determined in comparison to SARS-CoV-2 RT-PCR considered as gold standard. RESULTS: A total of 200 samples were included; 94 were RT-PCR positive. Median patients’ age was 38.36 years, 63.5 % were male. Overall sensitivity and specificity of the Standard TM Q COVID-19 Ag (SD Biosensor® Republic Korea) were 62.66% and 100%, the sensitivity was significantly higher (100%) in samples with high viral loads (Ct<29). CONCLUSIONS: This antigen-based immunofluorescence RDT could be the potential to become an important tool for the early diagnosis of SARS-CoV-2 particularly in situations with limited access to molecular methods particularly in rural area of Madagascar. In the context of the Covid-19 pandemic and following the increasing number of suspicious Covid-19 cases in Madagascar, Malagasy laboratories are overflowed mainly due to lack of human resource and available material restriction. The development and validation of rapid and easy-to-perform diagnostic methods are worth of interest and high priority. The aim of this prospective study was to evaluate the performances of a rapid immunochromatographic test for the detection of SARS-CoV-2 antigen, in comparison to Reverse transcription polymerase chain reaction (RT-PCR). The fluorescence immunochromatographic SARS-CoV-2 antigen test StandardTM Q COVID-19 Ag Test (SD Biosensor Republic Korea) was evaluated in samples derived from patients who were examined for disease categories. Diagnostic accuracy was determined in comparison to SARS-CoV-2 RT-PCR considered as gold standard. A total of 200 samples were included; 94 were RT-PCR positive. Median patients' age was 38.36 years, 63.5 % were male. Overall sensitivity and specificity of the Standard TM Q COVID-19 Ag (SD Biosensor ® Republic Korea) were 62.66% and 100%, the sensitivity was significantly higher (100%) in samples with high viral loads (Ct<29). This antigen-based immunofluorescence RDT could be the potential to become an important tool for the early diagnosis of SARS-CoV-2 particularly in situations with limited access to molecular methods particularly in rural area of Madagascar. individuals. Most often at the origin of a mild infectious syndrome, associating to varying degrees mild symptoms (fever, cough, myalgia, headache and digestive problems), SARS-CoV-2 can be the cause of serious pulmonary pathologies and sometimes death [1] . For rapid treatment and to control the epidemic, the biology laboratories take on a real challenge since the confirmation of the infection is based on virological diagnosis by molecular biology (extraction of the viral genome followed by amplification and revelation by RT-PCR) [2] . Currently, facing the increase number of cases, the human and material capacities available at the laboratory level are exceeded. The use of rapid tests of viral antigens which potentially detect early cases is currently proposed in order to identify the outbreaks, expand screening and follow-up treatment. However, these kits should be evaluated before their routine use. Among possible test formats, rapid diagnostic tests (RDTs) should be prioritized, since they are timely, easy to perform, and can serve as point-of-care testing (POCT). Here we present the evaluation of antigen-based RDT for the detection of SARS-CoV-2 in respiratory specimens from suspected Covid-19 cases. We conducted a prospective study which aimed to assess the performance of the RDT SARS-CoV2-StandardTM Q COVID-19 Ag Test (SD Biosensor ® Republic Korea) compared to RT-PCR which is the main biological testing used in Madagascar in order to confirm Covid-19. were less than 40 and negative when they were both greater than 40. If only one of the target genes had a Ct value of 38 or less and the other was more than 38, it was interpreted as a singlegene positive. StandardTM Q COVID-19 Ag Test (SD Biosensor ® Republic Korea), is a rapid chromatographic immunoassay ready to use test which allows rapid and qualitative detection of SARS-CoV-2 antigen in nasopharyngeal secretions. As instructed by the manufacturer, the specimen should be tested as soon as after collection or at room temperature for up to 1 hours. All test procedures except the reading of the cassette were performed under a BSL2 cabinet. Results of the RDT were compared to those of RT-PCR as reference method. The demographic and clinical data were obtained from the mandatory national Covid-19 notification forms and were analyzed anonymously. Results of the Standard TM Q COVID-19 Ag Test (SD Biosensor ® Republic Korea) were compared to those of RT-PCR as reference method; for samples with discordant result, tests were repeated. RT-PCR was considered as the gold standard for this evaluation, therefore positive and negative samples by molecular techniques were considered to be true positive and true negative samples, respectively. Statistical analysis considered the calculation of sensitivity, specificity, and Kappa coefficient using standard formulas. Test performance was analyzed as recommended by current CLSI guidelines. Sensitivity was further analyzed for certain subgroups such as severity of illness and RT-PCR Ct values. Steps were taken to maintain strict confidentiality when preparing the files. The prospective study was performed with the agreement signed by the patient. The search for a reliable rapid test that can be installed in remote areas even without electricity is worth of interest. One of the promising approaches is the rapid antigenic tests although they have not been recommended yet for the acute diagnosis of COVID-19 due to their low sensitivity. According to several studies, the analytical performance of these rapid antigenic tests depends on various factors including the viral load, the quality of the sample and the way it is processed. showing good sensitivity if the viral load was high (Ct <30) and a decrease in sensitivity after Ct values over 30. Considering our cohort of patients, the sensitivity of the test is increased in very symptomatic patients, even if the viral load that was detected in the asymptomatic patient was similar to that of symptomatic patients [4] . This could be explained by the fact that symptomatic patients exhibit a longer high viral load [5] . Considering that the viral loads in throat swabs and sputum have reached the maximum level after 5-6 days from the beginning of the infection, the SARS-CoV-2 Ag RDT has no indication in the follow-up of patients and the confirmation of viral clearance [7] . Any Antigen negative RDT in a person suspected of COVID-19 must be confirmed by RT-PCR. In low-income countries, the cost of the analysis certainly plays an important role in the number of screened people; interestingly the price of PCR turns around $ 50 while an Standard TM Q J o u r n a l P r e -p r o o f COVID-19 Ag (SD Biosensor ® Republic Korea) is less than $ 5.However, as for PCR the Standard TM Q COVID-19 Ag (SD Biosensor ® Republic Korea) is carried out from a nasopharyngeal sample; the handling of the collection sample must take into account the infectivity of the sample which may expose operator/environment and the management of the elimination of contaminated waste which oblige the handling in a biosafety cabinet following the WHO recommendation [8] . To date, there have been no reports of molecular tests or antigen-based immunofluorescence detection being affected by other mutations carried by the new variants. However, given the number of mutations in the S gene that each variant carries, laboratories that use tests with targeting the S gene are recommended to monitor for 'dropout' and consider implementing assays specific for other genomic targets. In conclusion, strength of this antigen-based immunofluorescence detection can be resumed to the easy-perform technic and provided results in a timely manner and its high sensitivity and specificity in respiratory samples obtained from patients with high viral load usually during the first week of Covid-19. Thus, this Standard TM Q COVID-19 Ag (SD Biosensor ® Republic Korea) could be an important tool for the early diagnosis of SARS-CoV-2 and consecutively helps reducing the delay in the establishment of adequate treatment particularly in rural area of Madagascar. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. All authors declare no competing interests. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak-United States Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients Virological assessment of hospitalized patients with COVID-2019 Distinguishing between COVID-19 and the common cold in a primary care setting-comparison of patients with positive and negative SARS-CoV-2 PCR results. medRxiv Viral load of SARS-CoV-2 in clinical samples Evaluation of novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples We thank the Ministry of Public Health of Madagascar for choosing our laboratory for the evaluation of Antigen-based rapid detection test.